Top-line Data Scheduled to Report in Q2 2022
Continue reading here:
Addex Therapeutics Completes Patient Enrollment for Dipraglurant Blepharospasm Phase 2 Clinical Study
Recommendation and review posted by Fredricko
Search Immortality Topics: |
Posted: April 13, 2022 at 1:50 am
Top-line Data Scheduled to Report in Q2 2022
Continue reading here:
Addex Therapeutics Completes Patient Enrollment for Dipraglurant Blepharospasm Phase 2 Clinical Study
Recommendation and review posted by Fredricko